Combined Erlotinib and Cetuximab overcome the acquired resistance to epidermal growth factor receptors tyrosine kinase inhibitor in non-small-cell lung cancer
Meng Wang, Jing Zhao, Lian-Min Zhang, Hui Li, Jin-Pu Yu, Xiu-Bao Ren, Chang-Li WangVolume:
138
Language:
english
DOI:
10.1007/s00432-012-1291-2
Date:
December, 2012
File:
PDF, 2.39 MB
english, 2012